74
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Antimetastatic activities of pegylated liposomal doxorubicin in a murine metastatic lung cancer model

, , , , &
Pages 679-687 | Received 15 Feb 2008, Accepted 14 May 2008, Published online: 03 Dec 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mukesh Ukawala, Kiran Chaudhari, Tushar Rajyaguru, A.S. Manjappa, R.S.R. Murthy & Rajiv Gude. (2012) Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis. Journal of Drug Targeting 20:1, pages 55-66.
Read now

Articles from other publishers (4)

Akshansh Sharma, Devanshi Shambhwani, Sadanand Pandey, Jay Singh, Hauzel Lalhlenmawia, Murali Kumarasamy, Sachin Kumar Singh, Dinesh Kumar Chellappan, Gaurav Gupta, Parteek Prasher, Kamal Dua & Deepak Kumar. (2022) Advances in Lung Cancer Treatment Using Nanomedicines. ACS Omega 8:1, pages 10-41.
Crossref
Christopher Woodman, Gugulethu Vundu, Alex George & Cornelia M. Wilson. (2021) Applications and strategies in nanodiagnosis and nanotherapy in lung cancer. Seminars in Cancer Biology 69, pages 349-364.
Crossref
Paulina Skupin-Mrugalska. 2019. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer 123 160 .
Mukesh Ukawala, Tushar Rajyaguru, Kiran Chaudhari, A. S. Manjappa, R. S. R. Murthy & Rajiv Gude. (2011) EILDV-conjugated, etoposide-loaded biodegradable polymeric micelles directing to tumor metastatic cells overexpressing α4β1 integrin. Cancer Nanotechnology 2:1-6, pages 133-145.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.